WHO血红蛋白海拔调整指南变化对全球贫血负担的影响
这项基于人群的建模研究使用相同调查数据,分别按WHO 2001和2024海拔调整方法估计1990-2023年204个国家的贫血患病率。
要点
- 患病率绝对增幅最大地区为海拔500-2000米区域。
研究设计与样本
- 基于人群的建模研究,使用相同一套人群调查血红蛋白数据,分别按WHO 2001和WHO 2024海拔调整方法生成两个数据集。
- 采用时空高斯过程回归和集成分布建模,估计1990-2023年204个国家和地区按年龄和性别的轻、中、重度贫血患病率。
- 在建模各步骤中通过采样后验分布来传播不确定性。
主要发现
- 贫血患病率绝对增幅最大的地区位于海拔500米至2000米之间,包括撒哈拉以南非洲东部、中亚、中美洲和南美洲的国家。
临床怎么用
- 政策制定者在设计贫血管理和预防干预措施时,应考虑WHO 2024海拔调整方法带来的患病率估计变化。
- 尤其应关注海拔500-2000米等受调整方法影响最大的地区。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adjustment of haemoglobin concentrations for elevation is essential for anaemia assessments of both individuals and populations. Whereas the previous WHO anaemia definitions released in 2001 used an elevation adjustment derived from small sample sizes with limited representativeness, the 2024 WHO global anaemia definitions reflect empirical assessments across several geographies and settings derived from population-representative surveys. We aimed to assess the effect of these changes on estimates of global anaemia burden. METHODS: In this population-based modelling study, using an identical set of input data from population-based surveys, we created two datasets in parallel, where each input haemoglobin concentration was adjusted using the WHO 2001 and WHO 2024 elevation adjustment methods. We estimated mild, moderate, and severe anaemia prevalence by age and sex for 204 countries and territories from 1990 to 2023 for each dataset using spatiotemporal Gaussian process regression and ensemble distribution modelling. We then analysed the overall differences in anaemia prevalence and years lived with disability to assess the effect of the WHO 2024 elevation adjustment method on the global landscape of anaemia. Uncertainty was propagated in each step of the modelling process by sampling draws of the posterior distribution of each estimated quantity. FINDINGS: Global anaemia prevalence for all ages and both sexes in 2023 was estimated to be 26·4% (95% uncertainty interval [UI] 22·6-31·9) using the WHO 2024 elevation adjustment method, which was 2·4 percentage points (2·2-2·7) higher than the total anaemia prevalence estimated using the WHO 2001 method (24·0% [20·6-29·3]). This increase equates to 198 million (196-199) newly enumerated cases, increasing the rank of anaemia from the third to the second largest cause of disability globally. The largest absolute increases in anaemia prevalence were in locations between 500 m and 2000 m in elevation, which include countries in eastern sub-Saharan Africa, central Asia, central America, and South America. INTERPRETATION: Understanding the effect of anaemia requires unbiased and comparable estimates of anaemia burden. To our knowledge, we produced the first set of global estimates of anaemia burden by location, year, age, and sex using the WHO 2024 elevation adjustment method and compared them with estimates using the previous method. Policy makers should consider this modification when designing interventions to manage and prevent anaemia, particularly in regions most affected by changes in elevation adjustment. FUNDING: Gates Foundation.
引用
- Teply CJ, Gardner WM, Noyes TS, et al. Implications of changes in WHO haemoglobin elevation adjustment guidelines on global, regional, and national anaemia burden, 1990-2023: a population-based modelling study. Lancet Haematol. 2026. PMID: 41934993. doi:10.1016/S2352-3026(26)00013-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。